Chris K. Neeley

Targeting CCL2 with Systemic Delivery of Neutralizing Antibodies Induces Prostate Cancer Tumor Regression<i>In vivo</i>

Robert D. Loberg, Ying Chi, Matt Craig et al. · Cancer Research · 2007 · 325 citations

CCL2 is a Potent Regulator of Prostate Cancer Cell Migration and Proliferation

Robert D. Loberg, LaShon L. Day, Jason Harwood et al. · Neoplasia · 2006 · 251 citations · Full text

An In Vivo Mouse Model for Human Prostate Cancer Metastasis

Aaron M. Havens, Elisabeth A. Pedersen, Yusuke Shiozawa et al. · Neoplasia · 2008 · 81 citations · Full text

Synergy between anti‐CCL2 and docetaxel as determined by DW‐MRI in a metastatic bone cancer model

Stefan Rozel, Craig J. Galbán, Klaas Nicolay et al. · Journal of Cellular Biochemistry · 2009 · 60 citations · Full text

Metastatic Prostate Cancer, Oncologic Imaging, Medicine +15

Differential expression analysis of MIM (MTSS1) splice variants and a functional role of MIM in prostate cancer cell biology

Robert D. Loberg, Chris K. Neeley, Lashon Adam-Day et al. · International Journal of Oncology · 2005 · 54 citations

Functional Role, Cancer Biology, Splicing Variant +16